Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Recent developments in the field include an evolving treatment landscape and the development of evidence-based guidelines.

The FDA expanded the approval of mirikizumab (Omvoh) to include treatment of adults with moderately to severely active Crohn's disease, drugmaker Eli Lilly announced; the first-in-class interleukin-23 ...